VYNT Shares Outstanding History
Below is a table of the VYNT shares outstanding history going back to 3/26/2021:

Date VYNT Shares Outstanding

Also see: VYNT Market Cap History
VYNT Historical Shares Outstanding:
+83.46% CAGR
VYNT Historical Shares Outstanding: +83.46% CAGR

Mouse over chart for data details
3/26/2021 ...11/10/2022
Vyant Bio is a biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. Co.'s central nervous system (CNS) drug discovery platform is designed to: elucidate disease pathophysiology; formulate key therapeutic hypotheses; identify and validate drug targets, cellular assays, and biomarkers to guide candidate molecule selection; and guide clinical trial patient selection and trial design. Co.'s programs are focused on identifying small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome, CDKL5 Deficiency Disorders and Parkinson's Disease. We show 8 historical shares outstanding datapoints in our coverage of VYNT's shares outstanding history.

Understanding the changing numbers of VYNT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VYNT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VYNT by allowing them to research VYNT shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree VYNT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Vyant Bio (VYNT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

WAT Shares Outstanding History
WCG Shares Outstanding History
WGS Shares Outstanding History
WINT Shares Outstanding History
WMGI Shares Outstanding History
WST Shares Outstanding History
XAIR Shares Outstanding History
XBIO Shares Outstanding History
XCUR Shares Outstanding History
XENT Shares Outstanding History
More Healthcare companies »


VYNT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2023, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.